EGFR-directed antibodies increase the risk of severe infection in cancer patients

por Altan, Mehmet, Burtness, Barbara
Publicado 2015

Immune-Related Adverse Events: Pneumonitis

por Zhong, Linda, Altan, Mehmet, Shannon, Vickie R., Sheshadri, Ajay
Publicado 2020

Emerging Therapies in Thoracic Malignancies—Immunotherapy, Targeted Therapy, and T-Cell Therapy in Non–Small Cell Lung Cancer

por Sepesi, Boris, Cascone, Tina, Chun, Stephen G., Altan, Mehmet, Le, Xiuning
Publicado 2020

Predicting response and toxicity to immune checkpoint inhibitors in lung cancer using antibodies to frameshift neoantigens

por Shen, Luhui, Brown, Justin R., Johnston, Stephen Albert, Altan, Mehmet, Sykes, Kathryn F.
Publicado 2023

Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)

por Carvajal-Hausdorf, Daniel, Altan, Mehmet, Velcheti, Vamsidhar, Gettinger, Scott N., Herbst, Roy S., Rimm, David L., Schalper, Kurt A.
Publicado 2019

Implementing an immunotherapy toxicity (IOTOX) GI service improves outcomes in patients with immune-mediated diarrhea and colitis

por Saji, Alice, Chopra, Maneera, Jacob, Jake, Altan, Mehmet, Alhalabi, Omar, Shah, Amishi Yogesh, Qiao, Wei, Wang, Yinghong, Thomas, Anusha
Publicado 2022

Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury

por Abu-Sbeih, Hamzah, Tang, Tenglong, Lu, Yang, Thirumurthi, Selvi, Altan, Mehmet, Jazaeri, Amir A., Dadu, Ramona, Coronel, Emmanuel, Wang, Yinghong
Publicado 2019

Does Post-COVID-19 Erectile Dysfunction Improve over Time?

por Gök, Alper, Altan, Mehmet, Doğan, Ahmet Emin, Eraslan, Aşır, Uysal, Fahrettin Şamil, Öztürk, Ufuk, Saguner, Ardan Muammer, İmamoğlu, Muhammet Abdurrahim
Publicado 2023

Correction to: Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis

por Abu-Sbeih, Hamzah, Herrera, Lauren Nicholas, Tang, Tenglong, Altan, Mehmet, Chaftari, Anne-Marie, Okhuysen, Pablo C., Jenq, Robert R., Wang, Yinghong
Publicado 2019

An assessment of neuronal calcium sensor-1 and response to neoadjuvant chemotherapy in breast cancer patients

por Moore, Lauren M., Wilkinson, Rachel, Altan, Mehmet, Toki, Maria, Carvajal-Hausdorf, Daniel E., McGuire, John, Ehrlich, Barbara E., Rimm, David L.
Publicado 2018

Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis

por Abu-Sbeih, Hamzah, Herrera, Lauren Nicholas, Tang, Tenglong, Altan, Mehmet, Chaftari, Anne-Maria P., Okhuysen, Pablo C., Jenq, Robert R., Wang, Yinghong
Publicado 2019

Case Report: Immune checkpoint inhibitor–induced multiorgan vasculitis successfully treated with rituximab

por Qureshi, Sehrish, Arani, Naszrin, Parvathareddy, Vishnu, Tchakarov, Amanda, Abdelrahim, Maen, Suarez-Almazor, Maria, Zhang, Jianjun, Gibbons, Don Lynn, Heymach, John, Altan, Mehmet, Abudayyeh, Ala
Publicado 2023

Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance

por Pelekanou, Vasiliki, Carvajal-Hausdorf, Daniel E., Altan, Mehmet, Wasserman, Brad, Carvajal-Hausdorf, Cristobal, Wimberly, Hallie, Brown, Jason, Lannin, Donald, Pusztai, Lajos, Rimm, David L.
Publicado 2017

Erratum to: Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance

por Pelekanou, Vasiliki, Carvajal-Hausdorf, Daniel E., Altan, Mehmet, Wasserman, Brad, Carvajal-Hausdorf, Cristobal, Wimberly, Hallie, Brown, Jason, Lannin, Donald, Pusztai, Lajos, Rimm, David L.
Publicado 2017

Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor–induced colitis

por Abu-Sbeih, Hamzah, Ali, Faisal S., Wang, Xuemei, Mallepally, Niharika, Chen, Ellie, Altan, Mehmet, Bresalier, Robert S., Charabaty, Aline, Dadu, Ramona, Jazaeri, Amir, Lashner, Bret, Wang, Yinghong
Publicado 2019

Clinical characteristics of colitis induced by taxane-based chemotherapy

por Chen, Ellie, Abu-Sbeih, Hamzah, Thirumurthi, Selvi, Mallepally, Niharika, Khurana, Shruti, Wei, Dongguang, Altan, Mehmet, Morris, Van K., Tan, Dongfeng, Barcenas, Carlos H., Wang, Yinghong
Publicado 2020

Cytomegalovirus infection among patients with cancer receiving immune checkpoint inhibitors

por Panneerselvam, Kavea, Szafron, David, Amin, Rajan N., Wei, Dongguang, Tan, Dongfeng, Altan, Mehmet, Okhuysen, Pablo C., Shatila, Malek, Raju, Gottumukkala Subba, Thomas, Anusha S., Wang, Yinghong
Publicado 2022

Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the Literature

por Soto, Felipe, Torre-Sada, Luis F., Mott, Frank E., Kim, Sang T., Nurieva, Roza, Shannon, Vickie R., Faiz, Saadia A., Casal, Roberto F., Altan, Mehmet, Lin, Julie, Sheshadri, Ajay
Publicado 2023

Association of B7-H4, PD-L1, and tumor infiltrating lymphocytes with outcomes in breast cancer

por Altan, Mehmet, Kidwell, Kelley M., Pelekanou, Vasiliki, Carvajal-Hausdorf, Daniel E., Schalper, Kurt A., Toki, Maria I., Thomas, Dafydd G., Sabel, Michael S., Hayes, Daniel F., Rimm, David L.
Publicado 2018

Physician Views on the Provision of Information on Immune Checkpoint Inhibitor Therapy to Patients with Cancer and Pre-Existing Autoimmune Disease: A Qualitative Study

por Lopez-Olivo, Maria A., Duhon, Gabrielle F., Ruiz, Juan I., Altan, Mehmet, Tawbi, Hussein, Diab, Adi, Bingham, Clifton O., Calabrese, Cassandra, Heredia, Natalia I., Volk, Robert J., Suarez-Almazor, Maria E.
Publicado 2023